“life-sciences” Archives

in
Entry Author Date Location
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3 09/13/17 New York
Akadeum Scores $1.5M to Advance Microbubble Cell-Sorting Technology 09/13/17 Detroit Ann Arbor
Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq 09/12/17 New York
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D 09/12/17 San Francisco
The Winners of the Xconomy Lifetime Achievement Award Are… 09/12/17 Boston
All Eyes on Depression Trials as Sage Neuro Drug Flunks Epilepsy Test 09/12/17 Boston
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing 09/11/17 New York
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Levin, Holtzman, 183 Other Bio Leaders Urge White House to Preserve DACA 09/07/17 National
Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others 09/07/17 New York
On Eve of Big Data Reveal, Patient Death Stalls Alnylam Hemophilia Drug 09/07/17 Boston
NextCODE Reloads With $240M, Eyes IPO, As Genomic Data Demand Grows 09/07/17 Boston
Lasker Award Goes to HPV Vaccine Developers Lowy, Schiller 09/06/17 National
Smartphone Medicine: Detecting Concussions With Machine Learning 09/06/17 Seattle
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO 09/06/17 Boston
As Key Data Loom, Nobel Winner Mello Reflects on RNAi “Sci-Fi” Story 09/06/17 Boston
Presage Bio Licenses Anti-Cancer Drug to San Diego’s MEI Pharma 09/05/17 San Diego
Catch Dragonfly, IFM, Tesaro at “Disruptors” on Sept. 28 09/05/17 Boston
Coming to Boston Was a “No-Brainer”: Xconomy’s Newcomer Award Finalists 09/05/17 Boston
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T 09/05/17 New York
U-M Life Sci Institute Looks Ahead with $150M Initiative, Symposium 09/04/17 Detroit Ann Arbor
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
Novartis: CAR-T Results In One Month, Or No Charge. Why One Month? 08/31/17 National
InVivo Therapeutics CSO Ulich Loses Job in Corporate Restructuring 08/31/17 Boston
BDSI’s Sirgo to Retire as CEO But Remain Vice Chairman 08/31/17 Raleigh Durham
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000 08/30/17 National
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission 08/30/17 Indiana
Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed 08/30/17 San Diego
Celgene Broadens Forma Deal, Adding $195M More for Drug R&D 08/29/17 New York
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
Page 2 of 337 « previous page · next page »